EmployblEmploybl logo
employbl
Freenome logo

Freenome Funding & Investors

Freenome, Inc. provides clinical research services. The Company develops and creates screening, diagnosis, and treatment of age-associated clinical conditions. Freenome serves patients and the healthcare sector in the United States.

freenome.com

Total Amount Raised: $1,097,550,080

Freenome Funding Rounds

  • Corporate Round

    $290,000,000

    Corporate Round Investors

    Roche

  • Series D

    $300,000,000

    Series D Investors

    Cormorant Capital
    Eventide
    Polaris Partners
    Bain Capital Life Sciences
    Suvretta Capital Management
    Fidelity Management and Research Company
    Farallon Capital Management
    Ridgeback Capital Management
    HBM Healthcare Investments
    Novartis
    Artis Ventures
    Catalio Capital Management
    Perceptive Advisors
    Section 32
    Rock Springs Capital
    Pura Vida Investments
    DCVC
    Logos Capital
    BrightEdge Fund
    Soleus Capital Management
    ArrowMark Partners
    Sands Capital Ventures
    Andreessen Horowitz
    Kaiser Permanente
    Byers Capital
    Roche Venture Fund
    Intermountain Healthcare
    Henderson Global Investors
    RA Capital Management
    T. Rowe Price
    GV

  • Series C

    $270,000,000

    Series C Investors

    DCVC
    Polaris Partners
    EcoR1 Capital
    Bain Capital Life Sciences
    BrightEdge Fund
    Soleus Capital Management
    Sands Capital Ventures
    Fidelity Management and Research Company
    Farallon Capital Management
    Andreessen Horowitz
    Novartis
    Catalio Capital Management
    Kaiser Permanente Ventures
    Perceptive Advisors
    Cormorant Asset Management
    Roche Venture Fund
    Henderson Global Investors
    Section 32
    RA Capital Management
    Rock Springs Capital
    GV
    T. Rowe Price

  • Series B

    $160,000,000

    Series B Investors

    Polaris Partners
    DCVC
    BrightEdge Fund
    Soleus Capital Management
    Longevity Vision Fund
    Andreessen Horowitz
    Verily Life Sciences
    Artis Ventures
    Kaiser Permanente Ventures
    dRx Capital
    Perceptive Advisors
    Roche Venture Fund
    Section 32
    RA Capital Management
    T. Rowe Price
    GV

  • Series A

    $7,000,000

    Series A Investors

    DCVC
    Polaris Partners
    Verily Life Sciences
    CRV (Charles River Ventures)
    Anne Wojcicki
    S28 Capital
    Section 32
    Asset Management Ventures
    Founders Fund
    GV
    Innovation Endeavors
    Andreessen Horowitz

  • Series A

    $65,000,000

    Series A Investors

    Polaris Partners
    DCVC
    Allen & Company
    Agent Capital
    S28 Capital
    AME Cloud Ventures
    Asset Management Ventures
    GV
    Founders Fund
    Innovation Endeavors
    Andreessen Horowitz
    Charles River Associates

  • Seed

    $5,550,000

    Seed Investors

    DCVC
    Third Kind Venture Capital
    Founders Fund
    Andreessen Horowitz
Funding info provided by Diffbot.